MarketPeel
Insider Trading Intelligence
Pricing
…
JB

Joseph Baroldi

IONS
EVP, CHIEF BUSINESS OFFICER · IONIS PHARMACEUTICALS INC · CIK 0001813775
FILING MIX · LIFETIME51%/49%
BUYS
49
SELLS
48
TOTAL VALUE
$9.37M
COMPANIES
2
ACTIVE SINCE
Feb 2021
HOLDINGS NOW
91,669
AVG SELL PX
$62.63
TRADE KIND
SHOWING 97 / 97
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
24 backtested trades · 8 horizons · 47 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Joseph Baroldi, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d24+45.83%+0.95%+0.70%+0.25%+0.69%—
14d24+45.83%+0.02%+0.83%-0.81%-1.41%—
30d24+50.00%+1.27%+1.80%-0.74%-1.32%—
60d24+54.17%+3.32%+3.60%-0.29%-2.22%—
90d24(2 pending)+59.09%+6.28%+4.20%+4.84%+2.64%—
180d24(10 pending)+21.43%+25.85%+9.53%+16.32%+18.31%—
1y24(16 pending)+37.50%+46.52%+21.70%+24.82%-3.25%—
2y24(19 pending)+40.00%+27.16%+45.24%-18.07%+0.05%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IONS · 4,669 shares · as of Jun 26, 2026
021,67543,35065,02586,7002023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 49 buys / 48 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
5,635$80.16$451.7K4,669Jun 26, 2026Jun 30, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
3,866——0Jun 26, 2026Jun 30, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
1,769——0Jun 26, 2026Jun 30, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
1,769$32.60$57.7K10,304Jun 26, 2026Jun 30, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
3,866$56.78$219.5K8,535Jun 26, 2026Jun 30, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
1,626$71.79$116.7K44,909Apr 28, 2026Apr 30, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
5,619$74.56$419.0K46,535Apr 16, 2026Apr 17, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
10,837——52,154Apr 15, 2026Apr 17, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
10,837——48,312Apr 15, 2026Apr 17, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
238$56.78$13.5K4,585Mar 4, 2026Mar 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
201$80.00$16.1K4,347Mar 4, 2026Mar 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
201——1,769Mar 4, 2026Mar 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
238$80.00$19.0K4,347Mar 4, 2026Mar 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
201$32.60$6.6K4,548Mar 4, 2026Mar 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
238——3,866Mar 4, 2026Mar 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
820$56.78$46.6K5,592Mar 3, 2026Mar 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
879——1,970Mar 3, 2026Mar 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
2,088$80.41$167.9K4,383Mar 3, 2026Mar 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
879$32.60$28.7K6,471Mar 3, 2026Mar 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
820——4,104Mar 3, 2026Mar 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
4,096$79.36$325.1K41,317Mar 3, 2026Mar 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
36$81.01$2.9K4,347Mar 3, 2026Mar 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
5,296$82.96$439.4K45,413Jan 30, 2026Feb 2, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
10,278——50,709Jan 29, 2026Feb 2, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
6,907$75.75$523.2K40,431Jan 16, 2026Jan 20, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
1,149$75.78$87.1K4,772Jan 16, 2026Jan 20, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
2,850——5,921Jan 15, 2026Jan 20, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
25,800——77,090Jan 15, 2026Jan 20, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
17,037——49,474Jan 15, 2026Jan 20, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
3,900——9,374Jan 15, 2026Jan 20, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
2,850——5,474Jan 15, 2026Jan 20, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
9,675——59,149Jan 15, 2026Jan 20, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
17,037——47,338Jan 15, 2026Jan 20, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,600——2,600Jan 2, 2026Jan 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
19,350——19,350Jan 2, 2026Jan 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
1,625$69.37$112.7K30,301Oct 6, 2025Oct 8, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
15,000——26,700Oct 2, 2025Oct 2, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
15,000$68.01$1.02M31,926Oct 2, 2025Oct 2, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
15,000$31.80$477.0K46,926Oct 2, 2025Oct 2, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
11,950$62.16$742.8K31,926Sep 9, 2025Sep 10, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
11,950$31.80$380.0K43,876Sep 9, 2025Sep 10, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
11,950——41,700Sep 9, 2025Sep 10, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
250——53,650Sep 5, 2025Sep 9, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$62.00$15.5K31,926Sep 5, 2025Sep 9, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
250$31.80$8.0K32,176Sep 5, 2025Sep 9, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
2,800$31.80$89.0K34,726Sep 3, 2025Sep 4, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
2,800$62.01$173.6K31,926Sep 3, 2025Sep 4, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
15,000$31.80$477.0K31,926Sep 3, 2025Sep 4, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
30,000$59.09$1.77M16,926Sep 3, 2025Sep 4, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
15,000——53,900Sep 3, 2025Sep 4, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
2,800——83,900Sep 3, 2025Sep 4, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
15,000——68,900Sep 3, 2025Sep 4, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
15,000$31.80$477.0K46,926Sep 3, 2025Sep 4, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
3,928$28.40$111.6K31,926Apr 16, 2025Apr 16, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
10,837——35,854Apr 15, 2025Apr 16, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
10,837——66,511Apr 15, 2025Apr 16, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
1,029$32.70$33.6K3,071Jan 16, 2025Jan 17, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
3,401$32.70$111.2K25,017Jan 16, 2025Jan 17, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
2,460——8,324Jan 15, 2025Jan 17, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
33,000——86,135Jan 15, 2025Jan 17, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
8,787——77,348Jan 15, 2025Jan 17, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
8,787——28,418Jan 15, 2025Jan 17, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
22,000——51,290Jan 15, 2025Jan 17, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
2,460——4,100Jan 15, 2025Jan 17, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
3,750——10,784Jan 15, 2025Jan 17, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
22,000——22,000Jan 2, 2025Jan 3, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,500——2,500Jan 2, 2025Jan 3, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
4,006$41.60$166.6K19,631Apr 16, 2024Apr 17, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
10,838——53,135Apr 15, 2024Apr 17, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
10,838——23,637Apr 15, 2024Apr 17, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
1,460$50.42$73.6K12,799Jan 17, 2024Jan 18, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
564$50.42$28.4K1,640Jan 17, 2024Jan 18, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
1,353——7,034Jan 16, 2024Jan 18, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
3,688——14,259Jan 16, 2024Jan 18, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
1,353——2,204Jan 16, 2024Jan 18, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
3,688——63,973Jan 16, 2024Jan 18, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
20,400——67,661Jan 15, 2024Jan 17, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,625——8,387Jan 15, 2024Jan 17, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,800——5,762Jan 15, 2024Jan 17, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
17,000——29,290Jan 15, 2024Jan 17, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
27,200——27,200Jan 2, 2024Jan 4, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
3,500——3,500Jan 2, 2024Jan 4, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,400——2,400Oct 1, 2023Nov 1, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
3,880$36.50$141.6K10,571Apr 18, 2023Apr 19, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
10,838——47,261Apr 17, 2023Apr 19, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
10,838——14,451Apr 17, 2023Apr 19, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
375$39.79$14.9K851Jan 18, 2023Jan 19, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chief Business Officer
904——1,226Jan 17, 2023Jan 19, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chief Business Officer
904——3,962Jan 17, 2023Jan 19, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,800——4,866Jan 15, 2023Jan 18, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
12,290——12,290Jan 15, 2023Jan 18, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
14,749——58,099Jan 15, 2023Jan 18, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
19,665——19,665Jan 3, 2023Jan 4, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,400——2,400Jan 3, 2023Jan 4, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
43,350——43,350Apr 15, 2022Apr 19, 2022 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
86,700——86,700Jan 31, 2022Feb 1, 2022 ↗View →
RNA
ATRIUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
87,000——87,000Feb 2, 2021Feb 4, 2021 ↗View →
Other insiders · IONS
Loading peer insiders…
About this filer
CIK 0001813775
ROLE
EVP, Chief Business Officer
PRIMARY
IONS
COMPANIES
2
ACTIVE SINCE
Feb 2021
MARKETPEEL · /INSIDER/0001813775DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback